Bazemore Robert B

CIK 00016201526 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001620152

Recent Transactions

50 trades

Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+123,731→ 123,731 total
Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+30,932→ 30,932 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase ADRs
2025-12-16+30,932→ 30,932 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase American Depositary Shares ("ADRs")
2025-12-16+123,731→ 123,731 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2025-06-18+54,059→ 54,059 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-06-18+41,551→ 41,551 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2025-05-21+292,983→ 292,983 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+225,000→ 225,000 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+175,000→ 175,000 total
Award
Akari Therapeutics Plc$AKTX
Series A Warrants (Right to Buy)
2025-03-06$1.12/sh+44,642→ 44,642 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-03-06$1.12/sh+44,642→ 44,642 total
Award
Akari Therapeutics Plc$AKTX
Series B Warrants (Right to Buy)
2025-03-06$1.12/sh+44,642→ 44,642 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2024-09-17+5,000,000→ 5,000,000 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2024-09-03+200,801→ 200,801 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2024-06-14+40,243→ 40,243 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2023-06-15+49,237→ 49,237 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2023-05-15+366,744→ 366,744 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2022-06-15+100,000→ 100,000 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2022-05-16+118,784→ 118,784 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2022-05-16+140,713→ 140,713 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2021-10-29+45,229→ 45,229 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2021-06-16+32,765→ 32,765 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2021-03-30$9.98/sh+5,000→ 5,000 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2021-03-25$7.85/sh−10,328→ 322,626 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2021-02-10+51,703→ 51,703 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2021-02-10+187,658→ 187,658 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2021-02-04$11.21/sh−3,890→ 331,977 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2021-02-01+417,443→ 417,443 total
Award
Epizyme, Inc.
Common Stock
2021-02-01+87,500→ 335,867 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2021-01-25$11.41/sh−6,069→ 248,367 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-06-26$16.15/sh−4,773→ 250,098 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2020-06-25+10,500→ 254,871 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001
2020-06-18$8.98/sh+10,000→ 264,371 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-06-18$22.00/sh−10,000→ 254,371 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2020-06-18−10,000→ 323,333 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-06-18$22.00/sh−10,000→ 244,371 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2020-06-09+23,500→ 23,500 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−28,000→ 0 total
Disposition to Issuer
Neon Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-06−18,500→ 0 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-03-25$15.28/sh−3,285→ 254,371 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2020-03-24+113,393→ 250,656 total
Other
Epizyme, Inc.
Common Stock, par value $0.0001
2020-03-24−56,537→ 80,726 total
Other
Epizyme, Inc.
Stock Option (Right to Buy)
2020-03-24−79,167→ 333,333 total
Other
Epizyme, Inc.
Stock Option (Right to Buy)
2020-03-24−48,727→ 298,737 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2020-03-24+73,409→ 73,409 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2020-03-24+7,000→ 257,656 total
Other
Epizyme, Inc.
Stock Option (Right to Buy)
2020-03-24−2,371→ 333,333 total
Award
Epizyme, Inc.
Common Stock
2020-02-03+52,595→ 137,263 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2020-02-03+252,956→ 252,956 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-01-27$20.44/sh−6,074→ 84,668 total

Bazemore Robert B

Recent Transactions

Companies

Recent Filings

Address